Table 1 Clinical characteristics of mothers with chronic HBV infection
AF mothers (n = 6) | NAF mothers (n = 14) | P value | |
|---|---|---|---|
Age (years) | 30.00 (25.25, 33.75) | 27.00 (26.00, 29.00) | 0.25 |
Gravidity | 1.00 (1.00, 1.50) | 1.00 (1.00, 2.00) | > 0.99 |
Parity | 1.00 (1.00, 1.50) | 1.00 (1.00, 1.25) | > 0.99 |
Delivery gestations (weeks) | 39.00 (38.75, 39.25) | 40.00 (38.00, 40.00) | 0.5 |
Duration of AVT (days) | 101.00 (91.00, 105.30) | 95.00 (79.25, 105.80) | 0.44 |
Type of delivery—no. (%) | |||
Vaginal | 5 (83.33%) | 11 (78.57%) | > 0.99 |
Caesarean section | 1 (16.67%) | 3 (21.43%) | |
Before AVT (gestational 26–28 weeks) | |||
ALT(U/L) | 22.00 (15.50, 23.50) | 21.00 (15.75, 24.25) | 0.7 |
AST(U/L) | 21.00 (16.50, 29.00) | 19.00 (16.75, 21.25) | 0.54 |
Gestational 30–32 weeks | |||
ALT(U/L) | 27.50 (16.00, 47.00) | 16.00 (12.75, 25.25) | 0.15 |
AST(U/L) | 29.00 (22.75, 34.00) | 20.59 (16.00, 22.00) | 0.05 |
Delivery | |||
ALT(U/L) | 17.50 (11.00, 24.50) | 18.00 (13.00, 20.00) | 0.94 |
AST(U/L) | 22.00 (15.25, 25.25) | 21.00 (16.25, 25.75) | 0.98 |
Postpartum 6–8 weeks | |||
ALT(U/L) | 38.00 (30.25, 98.50) | 38.00 (18.75, 47.75) | 0.41 |
ALT(n, > 2 × ULN) | 2 (33.33%) | 0 | 0.08 |
AST(U/L) | 29.50 (19.00, 86.50) | 25.50 (19.00, 36.00) | 0.51 |
AST(n, > 2 × ULN) | 2 (33.33%) | 0 | 0.08 |
Postpartum 15–18 weeks | |||
ALT(U/L) | 106.60 (40.00, 215.80) | 28.00 (23.50, 46.00) | 0.03 |
ALT(n, > 2 × ULN) | 4 (66.67%) | 0 | 0 |
AST(U/L) | 57.00 (33.75, 158.50) | 24.00 (21.00, 30.00) | 0 |
AST(n, > 2 × ULN) | 2 (33.33%) | 0 | 0.08 |